She cared for her husband every day, but not always kindly. He was a chain smoker living with lung cancer, and she had already settled the question of why he was sick. Some days her tone carried disdain; other days it came out as plain blame. Her attitude did nothing to help him heal, and it kept her from giving the care she was capable of giving.

Then the diagnosis arrived in her own family. Her mother, a woman who had never touched a cigarette in her life, was found to have lung cancer. What she had done for decades was cook, over charcoal and firewood, in a kitchen filled with smoke.

Something shifted in the wife that day. The story she had told herself, that smoking explains every case, no longer held up, and neither did the way she had been treating the man in the next room. Her mother’s illness did what no argument could: it showed her that lung cancer does not check a person’s habits before it arrives.  Exposure to biomass fuels, indoor smoke and other environmental and occupational hazards put many people at risk, including people who never lit a cigarette.

One household’s change of heart is easy to dismiss as a single anecdote, yet the same assumption shapes how a whole continent sees this disease. GLOBOCAN counted 49,831 new lung cancer cases across Africa in 2022, including 26,280 in Northern Africa and 9,446 in South Africa (Pretorius, 2026). West Africa tells the same story: GLOBOCAN’s latest estimates (2024) record 2,657 new lung cancer cases in Nigeria and 2,406 deaths, close to nine deaths for every ten cases (International Agency for Research on Cancer [IARC], 2026). A gap that narrow suggests many patients reach a clinic when little can still be done. The reasons go well beyond any one family. Care and referral pathways are hard to reach, diagnostic equipment is scarce, and health facilities are stretched thin. Some patients are even told they have tuberculosis and sent home with no onward referral (Nwagbara et al., 2020; Pretorius, 2026).

Stigma sits on top of all this. Blame for assumed smoking pushes patients toward distress and delays them from seeking help. A person who expects to be judged will wait, and with lung cancer, waiting costs lives, because earlier diagnosis reduces mortality. This is why stigma is not a side issue to be softened with kind words. It is a barrier to be removed, just like a missing machine or a missing referral.

Earlier diagnosis starts with knowing what to look for. See a health worker if you or someone close to you has a cough that lingers beyond three weeks, or one that changes in character. Coughing up blood, shortness of breath, chest pain that does not ease, a hoarse voice that will not clear, wheezing, and repeated chest infections all deserve attention. So do tiredness that rest does not fix and weight loss with no clear reason.

 

Many of these signs mimic tuberculosis, so if a cough persists despite treatment, or the diagnosis feels uncertain, ask for a chest X-ray or further tests and a referral. Do not wait for a cigarette to explain it, and do not let anyone else assume it for you.

The encouraging part is that barriers do move, and sometimes it begins with one conversation. In Abuja, an advocate wearing an IASLC T-shirt visited National Hospital and started talking with the head of oncology. The conversation exposed a problem hiding in plain sight: patients were walking long distances between the consultation room and the pathology lab, and they needed multiple tests before every chemotherapy cycle. By March 2023, a phlebotomy station with a dedicated phlebotomist was running. Hospital management bought in, and National Hospital went on to join an advisory board created by Move Against Cancer Africa. Not far away, in Piwoyi outside Abuja, Breathe to Live took prevention to the community, funded by an IASLC educational award to Isaac Joseph of Move Against Cancer Africa.

Yet campaigns alone do not shift budgets, guidelines or reimbursement. Those are decided behind four doors: health technology assessment and reimbursement, ministerial advisory structures, health insurers and funders, and regulators. Patients can enter each one, but the pace is slow. Trastuzumab was approved in 2001 and reached South Africa’s Essential Medicines List only in 2017. Sixteen years is a long time to wait for a drug, which is why patient voices must be in the room early, not after the decision is made (Mueller & Pretorius, 2025; Pretorius, 2026).

This November, Africa Lung Cancer Community of Practice (ALCCoP) and Move Against Cancer Africa are joining the global movement under one message: Africa Breathes: Know the Signs, Raise the Voice, Change the Story. Here is how you can answer it today. Learn the signs above and share them with your family, your church or mosque, your market and your workplace. Urge anyone with a stubborn cough to get checked. Remind one person that lung cancer is not only a smoker’s disease, and that no patient deserves blame. If you know someone living with the illness, offer your presence before your opinion. Every conversation counts, and the wife’s story shows how far one can travel.

Let us make this November count for every African lung cancer patient, from diagnosis to dignity.

 

 

References

  1. International Agency for Research on Cancer. (2026). Nigeria: GLOBOCAN 2024 fact sheet [Fact sheet]. Global Cancer Observatory. https://gco.iarc.who.int/media/globocan/factsheets/populations/566-nigeria-fact-sheet.pdf
  2. Mueller, D., & Pretorius, L. (2025). Role of the patient and citizen in health technology assessment and decision-making in South Africa. South African Journal of Public Health, 8(1), Article 2594. https://doi.org/10.7196/SHS.2025.v8i1.2594
  3. Nwagbara, U. I., Ginindza, T. G., & Hlongwana, K. W. (2020). Health systems influence on the pathways of care for lung cancer in low- and middle-income countries: A scoping review. Globalization and Health, 16, Article 23. https://doi.org/10.1186/s12992-020-00553-

 

 

Written by: Mrs Oge Akabuike

Edited by: Dr. Abiodun Egwuenu

Leave a Reply

Your email address will not be published. Required fields are marked *